Evaluation of the Talking Matters Teen Pregnancy Prevention Program

Status Completed

Clinical Trial Summary

A culturally tailored program that creates a safe, open space to increase knowledge, self-efficacy, skills, and comfort related to sexual and reproductive health, including HIV/STI and teen pregnancy prevention, mental health, and substance use risk reduction behavior, and strengthens protective factors, decision-making skills, and connections to trusted adults may help participants chart a path toward optimal health. To address a significant gap in evidence-based, culturally-tailored sexual and reproductive health services for Black and African American adolescents, Public Health Management Corporation (PHMC) is conducting a rigorous evaluation of an innovative group-level, two pronged intervention called Talking Matters using an individual randomized control trial (RCT) design. Due to social distancing guidelines during COVID-19 at the start of the study, all Talking Matters activities, including recruitment, screening, consent, intervention implementation, and data collection, will be conduct virtually and remotely. Developed and piloted over the past two years through FY2018 Phase I New and Innovative Strategies (Tier 2) to Prevent Teen Pregnancy and Promote Healthy Adolescence funding from the Office of Population Affairs (OPA), Talking Matters is a promising group-level, two-pronged intervention tailored for urban Black and African American 14 to 19 year old adolescents who are recruited from school- and community-based settings in Philadelphia, PA. Grounded in Social Cognitive Theory, the Transtheoretical Model, and Self-Determination Theory, and using evidence-based Motivational Interviewing strategies, the primary goals of Talking Matters are to reduce adolescents' risk for teen and unplanned pregnancy, sexually transmitted infections (STIs) and HIV, and to strengthen protective factors improve optimal health. The two prongs of Talking Matters include (1) an adolescent-focused five-session, group-level intervention called We Get to Choose (WGTC) and (2) an adult-focused three-session, group-level training called Let's Talk Real Talk (LTRT). An opportunity to connect WGTC participants to trusted adults who completed LTRT is provided during one facilitated session conducted each quarter. Adult participants of the LTRT training are not human subjects of the Talking Matters study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pregnancy in Adolescence

Clinical Trial Details

NCT number	NCT04970485
Study type	Interventional
Source	Public Health Management Corporation
Contact
Status	Completed
Phase	N/A
Start date	July 15, 2020
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06105905` - Latino Teen Pregnancy Prevention K23	N/A
Recruiting	`NCT05320666` - An Evaluation of the Yes You Can... Make Smart Choices Curriculum	N/A
Completed	`NCT01795885` - Trial of the Effect of "16 and Pregnant" on Teen Girls' Attitudes About Pregnancy	N/A
Completed	`NCT04120376` - Reducing Adolescent Pregnancy	N/A
Recruiting	`NCT03729726` - Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program	N/A
Completed	`NCT02709967` - Research Initiative to Support the Empowerment of Girls	N/A
Active, not recruiting	`NCT05383755` - Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV	N/A
Completed	`NCT04628065` - #BabyLetsMove Physical Activity Feasibility Trial	N/A
Active, not recruiting	`NCT01818791` - Enhancing Quality Interventions Promoting Healthy Sexuality	N/A
Completed	`NCT04198272` - Impact Evaluation of CyberRwanda: A Digital Health Intervention for Adolescents	N/A
Completed	`NCT01310543` - Trial of the Teens and Toddlers Intervention	Phase 3
Completed	`NCT05182736` - Taking Responsible Actions in Life Evaluation	N/A
Completed	`NCT02540278` - Evaluation of the Positive Prevention PLUS Program	N/A
Completed	`NCT03240887` - Evaluation of Peer Group Connection	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.